Late steroid therapy in primary acute lung injury.

Abstract

OBJECTIVE:

To investigate the effect of steroid treatment in the late phase of primary acute lung injury (ALI) with special emphasis on pneumococcal pneumonia.

DESIGN:

Retrospective study.

SETTING:

Multidisciplinary intensive care unit (ICU) in a university hospital.

PATIENTS:

Of 31 patients with primary ALI requiring mechanical ventilation for more than 10 days, 16 were treated with methylprednisolone and 15 served as controls.

MEASUREMENTS AND RESULTS:

Steroid and control groups were comparable regarding demographic data, APACHE II score, Multiple Organ Dysfunction Score (MODS), and PaO2/FiO2-ratio on admission to ICU. The mean start of steroid therapy was 9.7 days after establishment of respiratory failure, and values for control patients were registered on day 10. The PaO2/FiO2 ratio improved significantly within 3 days after the start of steroid therapy, and MODS and C-reactive protein decreased concurrently. No differences in mortality, in length of ICU stay, or in length of mechanical ventilation were detectable. In a subgroup analysis, for patients with Streptococcus pneumoniae pneumonia, beneficial change in physiological variables was evident.

CONCLUSIONS:

In patients with primary ALI, steroid therapy, started 10 days after the start of mechanical ventilation, improves gas exchange and is associated with a decrease in multiorgan dysfunction.

• Authors: T Varpula, V Pettilä, E Rintala, O Takkunen, V Valtonen
• Journal: Intensive care medicine (Intensive Care Med) Vol. 26 Issue 5 Pg. 526-31 (May 2000) ISSN: 0342-4642 [Print] United States
• PMID: 10923725 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Glucocorticoids
• Methylprednisolone

Topics

• APACHE
• Acute Disease
• Adult
• Case-Control Studies
• Female
• Glucocorticoids (therapeutic use)
• Humans
• Intensive Care Units
• Length of Stay
• Male
• Methylprednisolone (therapeutic use)
• Middle Aged
• Multiple Organ Failure (drug therapy, mortality, therapy)
• Pneumococcal Infections (classification, drug therapy, therapy)
• Respiration, Artificial
• Respiratory Distress Syndrome (classification, drug therapy, therapy)
• Retrospective Studies